A 12 cm Anterior Mediastinal Mass with Markedly Elevated Germ Cell Tumor Markers
A 26-year-old man presents with a 3-week history of dyspnea, facial swelling, and cough. CT shows a 12 cm anterior mediastinal mass compressing the superior vena cava and trachea. He has no prior malignancy, no testicular symptoms, and no weight loss. Serum alpha-fetoprotein is 420 ng/mL, beta-hCG 80 IU/L, and LDH 900 U/L. He is hypoxic when supine and has distended neck veins. He is 1.80 m and 70 kg; SpO2 is 94% upright but 86% supine, and chest CT shows tracheal narrowing to 8 mm at the level of the mass. A resident proposes CT-guided core biopsy and then surgery if the biopsy is non-diagnostic. The oncology team is concerned about airway compromise during sedation.
1. What is the diagnosis, and why is biopsy not the next step? What would you do instead?
Read the worked answer
The markedly elevated alpha-fetoprotein and beta-hCG in a young man with an anterior mediastinal mass are diagnostic of a nonseminomatous germ cell tumor. Biopsy is not required and is potentially harmful: it can cause bleeding, tumor seeding, and airway compromise during sedation, and it delays potentially curative chemotherapy. The correct next step is to confirm testicular ultrasound is normal, stage the disease with CT of the chest, abdomen, and pelvis and brain MRI, and refer urgently to a multidisciplinary germ cell tumor team. Chemotherapy with a cisplatin-based regimen such as BEP should start promptly. Surgery is not the initial treatment for a marker-positive nonseminomatous mediastinal germ cell tumor; it is reserved for residual mass after chemotherapy or for selected cases. If the markers were negative, biopsy would be needed, but they are not. The resident's plan is therefore the wrong sequence and exposes the patient to unnecessary anesthetic risk.
2. How would you manage the SVC obstruction and airway risk while starting treatment?
Read the worked answer
The SVC obstruction is due to a chemosensitive tumor, so chemotherapy is the definitive treatment and usually improves the obstruction within days to weeks. I would avoid SVC stenting unless there is life-threatening cerebral edema or airway compromise that cannot be managed medically, because stenting can complicate later resection and is rarely necessary in germ cell tumors. For airway risk, I would keep him upright, avoid sedation and general anesthesia unless absolutely necessary, and have a difficult airway plan with ear, nose, and throat and thoracic surgery available. If he needs a procedure, I would consider it under local anesthesia or with cardiopulmonary bypass standby. Corticosteroids may help reduce peritumoral edema but can complicate lymphoma diagnosis; here the diagnosis is already established by markers, so steroids are acceptable if needed for airway compromise. I would monitor him in a high-acuity unit during the first cycle of chemotherapy because tumor lysis and airway edema can worsen initially.
3. After chemotherapy, a residual 3 cm mass remains with normal markers. How do you decide between resection and observation?
Read the worked answer
A residual 3 cm mass with normal markers after chemotherapy for nonseminomatous germ cell tumor should generally be resected, because it may contain teratoma, viable germ cell tumor, or necrosis, and imaging cannot reliably distinguish these. The standard approach is to resect residual masses >1 cm, preferably at a center experienced in postchemotherapy retroperitoneal or mediastinal surgery. If the pathology shows necrosis, observation is appropriate; if it shows teratoma, complete resection is curative; if it shows viable tumor, further chemotherapy is needed. Observation alone risks missing viable tumor or teratoma, which can grow or undergo malignant transformation. The timing should be after markers normalize and after recovery from chemotherapy, usually within 4–6 weeks. Because this is a mediastinal primary, resection may require sternotomy and vascular reconstruction, so preoperative imaging and a multidisciplinary team are essential. I would not use PET-CT alone to avoid surgery; it cannot reliably exclude viable tumor.